Metabolism‐Based Molecular Subtyping Endows Effective Ketogenic Therapy in p53‐Mutant Colon Cancer

Although targeting cancer metabolism is a promising therapeutic strategy, clinical success depends on accurate molecular and metabolic subtyping. Here, this study reports two metabolism‐based molecular subtypes associated with the ketogenic treatment of colon cancer: glycolytic (glycolysis(+)/ketoly...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Meng, Xu, Hui, Huang, Hongyan, Kuang, Hao, Wang, Chenxi, Li, Qinqin, Zhang, Xin, Ge, Yizhong, Song, Mengmeng, Zhang, Xi, Wang, Ziwen, Ma, Chaobing, Kang, Jinlin, Zhang, Wanfang, Wang, You, Zhang, Bo, Zhang, Xiaowei, Chen, Yongbing, Cong, Minghua, Melino, Gerry, Wang, Xiaobin, Zhou, Fuxiang, Sun, Qiang, Shi, Hanping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561794/
https://www.ncbi.nlm.nih.gov/pubmed/36031388
http://dx.doi.org/10.1002/advs.202201992

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561794/
https://www.ncbi.nlm.nih.gov/pubmed/36031388
http://dx.doi.org/10.1002/advs.202201992

Ejemplares similares